# Targeting lysosomal pH restores mitochondrial quality control in GBA1-mutant Parkinson's disease.

- **DOI:** [10.1186/s40035-026-00559-z](https://doi.org/10.1186/s40035-026-00559-z)
- **Rating:** Sound (3.0 out of 5)
- **Verdict:** Patient-derived models link GBA1 mutations to lysosomal and mitochondrial dysfunction, but a pH-sensitive mitophagy reporter weakens the proposed causal rescue mechanism.
- **Framework version:** v5.9
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-10-08
- **Evaluation page:** https://www.nabu.science/paper/10.1186%2Fs40035-026-00559-z

## Key claims

1. the disruption of V-ATPase assembly driven by MTORC1 activation impairs lysosomal acidification. This causes impairment of mitophagy, leading to mitochondrial dysfunction
   - Support: Tentative
   - Type: Primary finding
   - Basis: the causal chain relies on one MTORC1 inhibitor and a pH-sensitive mitophagy reporter
   - Location: Abstract, Conclusions
2. GCase activity, lysosomal acidification, protease activity, mitophagy and mitochondrial bioenergetic function were all impaired in GBA1 mutant dopaminergic neurons.
   - Support: Supported
   - Type: Secondary
   - Basis: isogenic comparisons support the phenotype, although the mitophagy measure is sensitive to lysosomal acidity
   - Location: Abstract; Results, Figs. 1–3
3. Rapamycin and lysosome-targeting acidic nanoparticles rescued lysosomal pH and restored mitophagy, mitochondrial membrane potential and mitochondrial oxidative phosphorylation complex level in the GBA1 mutant dopaminergic neurons.
   - Support: Tentative
   - Type: Secondary
   - Basis: pH-sensitive mt-Keima and complex-specific protein changes do not establish broad functional rescue
   - Location: Abstract; Results, Fig. 5 and Fig. S4i
4. FLIM-FRET measurements confirmed impairment of lysosomal V-ATPase assembly, which was reversed by rapamycin treatment.
   - Support: Supported
   - Type: Secondary
   - Basis: fibroblast FLIM-FRET and fractionation support impaired assembly, but rapamycin reversal is partial and not neuronally replicated by FLIM
   - Location: Abstract; Results, Fig. 4

## Strengths

- **Isogenic patient-cell comparisons across variants** E326K and N370S patient-derived neurons are compared with CRISPR-corrected isogenic controls across lysosomal, mitochondrial, and mitophagy-associated endpoints.
  - Dimension: methodological rigour
  - Location: Results, opening paragraph; Figs. 1–5; Table S1
- **Convergent lysosomal and mitochondrial phenotyping** Lysosensor, DQRed BSA, TMRM, TEM, Seahorse respirometry, lysosomal fractionation, and FLIM-FRET address distinct parts of the proposed cellular pathway.
  - Dimension: contribution
  - Location: Methods; Results, Figs. 1–4
- **Competing mechanisms receive substantive discussion** The discussion compares the findings with direct mitochondrial GBA1 and mitochondria–lysosome contact models and identifies unresolved MTORC1 activation as a remaining gap.
  - Dimension: positioning
  - Location: Discussion, paragraphs on TBC1D15, complex I, and MTORC1

## Limitations

- **Mitophagy rescue is not independently identified** Because mt-Keima reports mitochondrial exposure to acidic environments, lowering lysosomal pH can increase its signal without demonstrating increased mitophagic delivery or flux.
  - Dimension: methodological rigour
  - Location: Methods, Measurement of Mitophagy Using mt-Keima Reporter; Results, Fig. 5c
- **Causal and functional language overreaches** The conclusions state that lysosomal pH restoration rescues mitophagy and therefore mitochondrial function, although respiration was not re-measured after treatment and cell fate was not assessed.
  - Dimension: reporting
  - Location: Abstract; Conclusions; Results, Fig. 5 and Fig. S4i
- **Intervention statistics and reporting conflict** Fig. 5 uses uncorrected Fisher’s LSD despite the methods stating that adjusted P-values are reported for multiple comparisons; complex I direction also conflicts between baseline and rescue text.
  - Dimension: methodological rigour
  - Location: Methods, Quantification and Statistical Analysis; Fig. 5 legend; Results, Fig. 2e and Fig. S4i

## Reliability checks

Caveats (4 of 4 checks).

- **Results check:** Noted
  - Rapamycin and lysosome-targeting acidic nanoparticles rescued lysosomal pH and restored mitophagy, mitochondrial membrane potential and mitochondrial oxidative phosphorylation complex level in the GBA1 mutant dopaminergic neurons: "increased expression of complex I proteins in N370S DA" (Results, Mitochondria are dysfunctional in cells with GBA1-PD mutations, Fig. 2e) vs "the reduced complex I level in the N370S DA neurons were normalised upon treatment with either rapamycin or acidic NPs." (Results, Acidification of lysosomes is sufficient to restore lysosomal and mitochondrial functions as well as mitophagy, Fig. S4i). The baseline Results describe increased N370S complex I expression, whereas the rescue paragraph describes normalisation of a reduced baseline level. → Not supported by the paper's own data
- **Reporting and transparency:** Noted. Reporting gaps concern the adjustment policy for rescue comparisons, the definition of sample size and statistical tests, the absence of an explicit ethics approval declaration, and the lysosomal protein-loading unit.
  - Ethics approval: not stated · Data availability: declared
- **Reference integrity:** Clean
  - 79 references in manuscript
  - 79 of 79 checkable references found in an index
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
